A recent study identified the up-regulation of miR-223 and miR-15 in human induced pluripotent stem cells (hiPSCs) derived from PTPN11 mutated JMML patients [20]. This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.